34,619 Shares in Avantor, Inc. $AVTR Acquired by Aristeia Capital L.L.C.

Key Points

• Aristeia Capital L.L.C. has invested $561,000 in Avantor, Inc., acquiring 34,619 shares in the first quarter, signaling confidence in the company's potential.
• Institutional investors and hedge funds dominate Avantor's ownership, holding 95.08% of the company's stock as of the latest updates.
• Avantor's recent financial performance showed a net margin of 10.31% and a decline in revenue by 1.1% compared to the previous year, with analysts predicting an EPS of 1.06 for the current fiscal year.

Aristeia Capital L.L.C. purchased a new stake in shares of Avantor, Inc. (NYSE:AVTR - Free Report) during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 34,619 shares of the company's stock, valued at approximately $561,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. Rise Advisors LLC bought a new position in Avantor during the first quarter valued at approximately $25,000. Northwestern Mutual Wealth Management Co. lifted its stake in Avantor by 288.4% in the first quarter. Northwestern Mutual Wealth Management Co. now owns 1,701 shares of the company's stock worth $28,000 after acquiring an additional 1,263 shares during the period. Wealthquest Corp purchased a new stake in Avantor in the first quarter worth $34,000. GAMMA Investing LLC lifted its stake in Avantor by 121.6% in the first quarter. GAMMA Investing LLC now owns 3,747 shares of the company's stock worth $61,000 after acquiring an additional 2,056 shares during the period. Finally, Fifth Third Bancorp lifted its stake in Avantor by 52.0% in the first quarter. Fifth Third Bancorp now owns 3,972 shares of the company's stock worth $64,000 after acquiring an additional 1,359 shares during the period. 95.08% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

AVTR has been the subject of a number of research analyst reports. Barclays reaffirmed an "overweight" rating and issued a $13.00 price target (down previously from $15.00) on shares of Avantor in a research note on Monday, August 4th. Wells Fargo & Company lowered their price objective on Avantor from $19.00 to $16.00 and set an "overweight" rating for the company in a research report on Monday, August 4th. Robert W. Baird lowered their price objective on Avantor from $18.00 to $15.00 and set an "outperform" rating for the company in a research report on Monday, August 4th. Raymond James Financial set a $14.00 price objective on Avantor and gave the company an "outperform" rating in a research report on Monday, August 4th. Finally, Morgan Stanley lowered their price objective on Avantor from $15.00 to $12.00 and set an "equal weight" rating for the company in a research report on Monday, August 4th. Seven equities research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company. Based on data from MarketBeat.com, Avantor presently has an average rating of "Hold" and a consensus price target of $15.50.

Insider Buying and Selling

In related news, CAO Steven W. Eck sold 3,476 shares of Avantor stock in a transaction dated Tuesday, August 5th. The stock was sold at an average price of $11.39, for a total value of $39,591.64. Following the completion of the sale, the chief accounting officer directly owned 55,068 shares in the company, valued at approximately $627,224.52. This trade represents a 5.94% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 1.20% of the company's stock.

Avantor Stock Down 5.2%

Shares of AVTR traded down $0.68 during trading hours on Friday, hitting $12.33. The company had a trading volume of 6,193,861 shares, compared to its average volume of 10,920,702. Avantor, Inc. has a 52-week low of $10.82 and a 52-week high of $27.83. The firm has a fifty day moving average price of $12.99 and a 200-day moving average price of $13.93. The stock has a market capitalization of $8.41 billion, a price-to-earnings ratio of 12.45, a P/E/G ratio of 1.48 and a beta of 0.98. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.67 and a current ratio of 0.98.

Avantor (NYSE:AVTR - Get Free Report) last released its quarterly earnings data on Friday, August 1st. The company reported $0.24 EPS for the quarter, missing the consensus estimate of $0.25 by ($0.01). Avantor had a return on equity of 11.39% and a net margin of 10.31%.The business had revenue of $1.68 billion during the quarter, compared to the consensus estimate of $1.67 billion. During the same quarter in the previous year, the business posted $0.25 earnings per share. Avantor's quarterly revenue was down 1.1% compared to the same quarter last year. On average, equities research analysts forecast that Avantor, Inc. will post 1.06 EPS for the current fiscal year.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.